SPONSOR
Shanghai Chest Hospital
Total Trials
6
Recruiting
6
Phases
Phase 2, Phase 3, Phase 1, Phase 2
Conditions studied: Locally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC)Ground-Glass OpacityStage II-III Non-small Cell Lung CancerEsophageal Squamous Cell CarcinomaUnresectable Locally Advanced Esophageal CancerEsophageal CancerLung LesionsMediastinal and Hilar Lymph Node Enlargement
NCT07058519 Phase 2
Recruiting
A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC
Locally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC)
NCT06848881
Recruiting
Cryoablation vs Thoracoscopic Surgery for GGN
Ground-Glass Opacity
NCT06437977 Phase 3
Recruiting
Neoadjuvant Therapy of SBRT Sequencial with Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH)
Stage II-III Non-small Cell Lung Cancer
NCT06173986 Phase 1, Phase 2
Recruiting
Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer
Esophageal Squamous Cell Carcinoma
NCT04135664 Phase 3
Recruiting
Comparison of Esophagectomy and Chemoradiation for Patients With cN0-pT1b Stage Esophageal Squamous Cell Carcinoma
Esophageal Cancer
NCT07060378
Recruiting
A Study of Contrast-enhanced EBUS in Lung Lesions and Intrathoracic Lymph Nodes
Lung Lesions